Mylan Says PPI Formulary Impact Unclear As Omeprazole Options Increase

Prescription proton pump inhibitor manufacturers are becoming increasingly wary of the effect Prilosec OTC will have on the formulary status of generic offerings

More from Archive

More from Pink Sheet